Completed NA INTERVENTIONAL 2-arm NCT03734770

Patient's Preferences About Subcutaneous or Vaginal Progesterone Administration for Luteal Phase Support (PROPER-1)

Patient's Preferences About Subcutaneous or Vaginal Progesterone Administration for Luteal Phase Support: Prospective Randomized Trial.

Sponsor: Universita di Verona

Conditions In Vitro Fertilization Luteal Phase Support Progesterone

Interventions Subcutaneous Progesterone Vaginal progesterone

Updated 6 times since 2018 Last updated: May 11, 2022 Started: Jan 1, 2019 Primary completion: Mar 1, 2019 Completion: Jul 1, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on In Vitro Fertilization and Luteal Phase Support, this trial is completed. The trial is conducted by Universita di Verona and has accumulated 6 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jun 2022 — Jul 2024 [monthly]

Completed NA

Status: Unknown Status → Completed
Jan 2021 — Jun 2022 [monthly]

Unknown Status NA
Dec 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status

▶ Show 1 earlier version

Dec 2018 — Dec 2020 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universita di Verona

Data source: Universita di Verona

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Verona, Italy